CompletedPhase 2

Subcutaneous Immunoglobulin Treatment for Multifocal Motor Neuropathy

Denmark10 participantsStarted 2005-08

Plain-language summary

The purpose of this study is to evaluate the effect of subcutaneous administration of immunoglobulin compared to intravenous treatment, for multifocal motor neuropathy NB. ONLY RECRUITING FROM DENMARK

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: \- Clinical diagnosis of multifocal motor neuropathy, supported by electrophysiological findings Exclusion Criteria: * Other severe medical conditions * Pregnancy and lactation * Anti-coagulation therapy

What they're measuring

Isokinetic muscle strength at the three most affected muscle groups.

Timeframe: At the end of each arm of the crossover study

Trial details

NCT IDNCT00268788

SponsorUniversity of Aarhus

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2008-02

View on ClinicalTrials.gov More Multifocal Motor Neuropathy trials